Active Biotech
0.07 SEK
-0.84 %
ACTI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Active Biotech operates in the pharmaceutical industry and focuses on the development of innovative treatments for cancer and autoimmune diseases. The company researches new therapies that can improve patient outcomes and quality of life. The project portfolio includes both small, orally active immunomodulatory molecules and antibody-based immunotherapy. The company operates globally. Active Biotech was founded in 1998 and is headquartered in Lund.
Read moreRevenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
Interim report Q2'26
Interim report Q3'26
Annual report '26
Annual General Meeting of Active Biotech AB
Active Biotech: Jakt på partnerskap - Analysguiden
Join Inderes community
Don't miss out - create an account and get all the possible benefits